37 /100
MEDIUM RISK
Score updated Jul 13, 2026

WHWK — Whitehawk Therapeutics, Inc. Dilution Risk Tracker

Track WHWK dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track WHWK — Get alerts when the score changes →

As of July 13, 2026, Whitehawk Therapeutics, Inc. (WHWK) has a DilutionWatch DilutionScore of 37/100, rated MEDIUM dilution risk. Whitehawk Therapeutics, Inc. has a market capitalization of $233.42M, 49.45M shares outstanding, 10 institutional holders tracked. Key dilution vectors include 317.6K outstanding warrants, approximately 20 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
25
📊 Float Risk
60
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for WHWK.
🔔 Track WHWK — Get forecast alerts →

💹 Market Data

Market Cap$233.42M
Shares Outstanding49.45M
Float18.15M
Cash$123.04M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 27.83M shares
#1 QVT Financial LP 4.62M shares
#2 Orbimed Advisors LLC. 4.17M shares
#3 Suvretta Capital Management, LLC 3.70M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest2.83M
Days to Cover3.4
% of Float15.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2023
xbrl XBRL CONVERTIBLE Dec 31, 2022
Form 4 INSIDER TRANSACTION Apr 16, 2026
Form 4 INSIDER TRANSACTION Apr 14, 2026
Form 4 INSIDER TRANSACTION Apr 10, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for WHWK Shareholders

Whitehawk Therapeutics, Inc. (WHWK) has a DilutionScore of 37/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch tracks 317,562 outstanding warrants for WHWK. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for WHWK in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for WHWK alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track WHWK Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking WHWK — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for WHWK
📊 WHWK FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 WHWK Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.